Systemic Therapy of Non-Resectable Metastatic Melanoma

Cancers

Azadeh Orouji¹  Sergij Goerdt¹ 

[1] Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany;

关键词: melanoma;    metastatic;    chemotherapy;    targeted therapy;    small molecules;   

DOI  :  10.3390/cancers2020955

来源: mdpi

【 摘 要 】

In advanced metastatic melanoma (non-resectable stage III/IV), the prognosis still remains poor, with median survival times between six and twelve months. Systemic therapeutic approaches for metastatic melanoma include chemotherapy, immunotherapy, immunochemotherapy, small molecules and targeted therapy. In this review, we will focus on the various treatment modalities as well as new agents used for targeted therapy.

【 授权许可】

CC BY   
© 2010 by the authors; licensee MDPI, Basel, Switzerland.